Who
Glenn S. Boehnlein
Director
Company insider
Files Form 4 as: Director, DexCom; Director, Agilent Technologies; Director, Inogen; VP, Chief Financial Officer, Stryker.
In numbers
- Trades disclosed
- 112
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $25.8M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 27 Apr 2016
- Last trade
- 10 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 10 Sep 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —5,841 at $0.00 | filing |
| 10 Sep 2026filed 10 Sep 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —5,841 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | A Agilent TechnologiesLife-science tools | SEC FORM 4 Code A | $120K817 at $146.85 | filing |
| 8 Sep 2026filed 10 Sep 2026 | A Agilent TechnologiesLife-science tools | SEC FORM 4 Code A | $120K817 at $146.85 | filing |
| 5 Jun 2026filed 9 Jun 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | —28,081 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | INGN InogenMedical Devices | SEC FORM 4 Code A | —28,081 at $0.00 | filing |
| 14 May 2025filed 19 May 2025 | INGN InogenMedical Devices | SEC FORM 4 Code A | —30,612 at $0.00 | filing |
| 21 Mar 2025filed 25 Mar 2025 | SYK Strykeroption or derivative · Medical Devices | SEC FORM 4 Code M | —314 at $0.00 | filing |
| 21 Mar 2025filed 25 Mar 2025 | SYK StrykerMedical Devices | SEC FORM 4 Code M | —314 at $0.00 | filing |
| 21 Mar 2025filed 25 Mar 2025 | SYK StrykerMedical Devices | SEC FORM 4 Code F | $2.5M6,720 at $374.22 | filing |
| 10 Mar 2025filed 12 Mar 2025 | SYK StrykerMedical Devices | SEC FORM 4 Code A | —12,916 at $0.00 | filing |
| 31 Dec 2024filed 2 Jan 2025 | SYK Strykeroption or derivative · Medical Devices | SEC FORM 4 Code M | —300 at $0.00 | filing |
| 31 Dec 2024filed 2 Jan 2025 | SYK StrykerMedical Devices | SEC FORM 4 Code M | $37K300 at $122.51 | filing |
| 31 Dec 2024filed 2 Jan 2025 | SYK StrykerMedical Devices | SEC FORM 4 Code F | $74K203 at $362.26 | filing |
| 27 Dec 2024filed 30 Dec 2024 | SYK Strykeroption or derivative · Medical Devices | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 27 Dec 2024filed 30 Dec 2024 | SYK StrykerMedical Devices | SEC FORM 4 Code M | $245K2,000 at $122.51 | filing |
| 27 Dec 2024filed 30 Dec 2024 | SYK StrykerMedical Devices | SEC FORM 4 Code F | $496K1,342 at $369.42 | filing |
| 18 Nov 2024filed 19 Nov 2024 | SYK Strykeroption or derivative · Medical Devices | SEC FORM 4 Code M | —4,500 at $0.00 | filing |
| 18 Nov 2024filed 19 Nov 2024 | SYK StrykerMedical Devices | SEC FORM 4 Code M | $551K4,500 at $122.51 | filing |
| 18 Nov 2024filed 19 Nov 2024 | SYK StrykerMedical Devices | SEC FORM 4 Code F | $1.2M2,979 at $390.08 | filing |
News
Stryker (SYK) Is Changing CEOs After the Stock Fell 25% Over Twelve MonthsSYK · insidermonkey.com · 9 Oct 2026Head to Head Review: Stryker (NYSE:SYK) & DIH Holding US (OTCMKTS:DHAI)SYK · dailypolitical.com · 7 Oct 2026Stryker (SYK) vs Boston Scientific (BSX): Which is a Better Stock to Buy?SYK · insidermonkey.com · 7 Oct 2026
0 headlines in the last 90 days name Glenn S. Boehnlein; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.